Thomas Massie actually said...

Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focused.

H.R. 3 really would completely gut the pharmaceutical innovations which we all so desperately need and we rely upon.

I ask unanimous consent to submit into the record two press releases from the U.S. Post Office.

I hope that members of this committee are aware that the U.S. Government ceases to be funded on September 30 of this year.